Clinical trial
Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With…
NCT00473642 · Oklahoma State University Center for Health Sciences, Other · Completed
Key facts
| NCT number | NCT00473642 |
|---|---|
| Title | Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration |
| Official title | A Prospective Pilot Study of Reduced Fluence Photodynamic Therapy With Visudyne® (Verteporfin) in Combination With Lucentis™ (Ranibizumab) for the Treatment of Age-Related Macular Degeneration |
| Lead sponsor | Oklahoma State University Center for Health Sciences, Other |
| Collaborators | Novartis Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Age-Related Maculopathy, Choroidal Neovascularization |
| Intervention type | Drug |
| Interventions | Ranibizumab, Verteporfin |
| Enrollment | 31 |
| Start date | May 1, 2007 |
| Primary completion | May 1, 2009 |
| Completion | Apr 1, 2010 |
| First posted | May 15, 2007 |
| Last update posted | Nov 6, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: